⏱ News is delayed by 15 minutes. Sign in for real-time access.
Sign in
MREO News
Mereo BioPharma Group plc American Depositary Shares
Form 8-K
sec.gov
MREO
Form 8-K
sec.gov
MREO
Mereo BioPharma Reports Second Quarter 2026 Financial Results and Provides Corporate Highlights
globenewswire.com
MREO
Form 8-K
sec.gov
MREO
Sentynl Therapeutics and Mereo BioPharma Announce Option and License Agreement for alvelestat in Alpha-1 Antitrypsin Deficiency-Associated Lung Disease (AATD-LD)
prnewswire.com
MREO
Mereo BioPharma and Sentynl Therapeutics Announce Option and License Agreement for alvelestat in Alpha-1 Antitrypsin Deficiency-Associated Lung Disease (AATD-LD)
globenewswire.com
MREO
Form 8-K
sec.gov
MREO
4basebio Announces Appointment of Chief Financial Officer and Board Changes
globenewswire.com
NBIX
MREO
Form 8-K/A
sec.gov
MREO
Form 8-K
sec.gov
MREO